Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men -: Proposal of reference values for defining lipodystrophy

被引:77
作者
Bonnet, E
Delpierre, C
Sommet, A
Marion-Latard, F
Hervé, R
Aquilina, C
Labau, E
Obadia, M
Marchou, B
Massip, R
Perret, B
Bernard, J
机构
[1] Hop Purpan, Unit Infect & Trop Dis, F-31059 Toulouse, France
[2] Hop Purpan, INSERM, U 563, F-31059 Toulouse, France
[3] Hop Rangueil, Rheumatol Unit, Toulouse, France
[4] Grave Hosp, Unit Dermatol, Toulouse, France
[5] INSERM, U558, Unit Epidemiol & Publ Hlth, Toulouse, France
关键词
HIV; lipodystrophy; DXA; fat mass ratio; antiretroviral drugs; bone mineral density;
D O I
10.1385/JCD:8:3:287
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to define standard values for fat mass distribution by dual-energy X-ray absorptiometry in human immunodeficiency virus (HIV)-negative men and to analyze factors associated with lipodystrophy in HIV-infected men. Total-body composition was analyzed in 241 HIV-negative men (controls) and 162 HIV-infected men. We created a fat mass ratio (FMR) as the ratio of the percentage of the trunk fat mass to the percentage of the lower limbs fat mass. We defined the FMR standard values as the mean value +/- standard deviation. We compared body mass index (BMI), fat mass percentage (%FM), lean mass (LM), bone mineral density (BMD), and FMR between the control group and HIV-infected men, by age range, according to prescription of treatment and presence of clinical lipodystrophy. The FMR standard value is equal to 1.3 +/- 0.2. The FMR was higher in treated HIV-infected men with or without clinical lipodystrophy. The FMR was similar for naive HIV-infected men and controls. It was positively correlated with age, cumulative time on treatment, zidovudine, stavudine, or indinavir. BMD and fat mass were lower for treated and naYve HIV-infected men than for HIV-negative men. The FMR seems to be a valuable index for measuring fat mass distribution. We defined FMR standard values from the largest group of HIV-negative men to our knowledge. Applying FMR to HIV patients could help physicians to diagnose lipodystrophy earlier.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 35 条
  • [1] BMD is reduced in HIV-infected men irrespective of treatment
    Amiel, C
    Ostertag, A
    Slama, L
    Baudoin, C
    N'Guyen, T
    Lajeunie, E
    Neit-Ngeilh, L
    Rozenbaum, W
    De Vernejoul, MC
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) : 402 - 409
  • [2] Metabolic bone disease in human immunodeficiency virus-infected children
    Arpadi, S
    Horlick, M
    Shane, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 21 - 23
  • [3] Arpadi SM, 2001, J ACQ IMMUN DEF SYND, V27, P30, DOI 10.1097/00126334-200105010-00005
  • [4] BONNET E, 2001, 4 INT C NUTR HIV INF
  • [5] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study
    Carr, A
    Samaras, K
    Thorisdottir, A
    Kaufmann, GR
    Chisholm, DJ
    Cooper, DA
    [J]. LANCET, 1999, 353 (9170) : 2093 - 2099
  • [6] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
    Carr, A
    Samaras, K
    Burton, S
    Law, M
    Freund, J
    Chisholm, DJ
    Cooper, DA
    [J]. AIDS, 1998, 12 (07) : F51 - F58
  • [7] Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy
    Carr, A
    Miller, J
    Eisman, JA
    Cooper, DA
    [J]. AIDS, 2001, 15 (06) : 703 - 709
  • [8] Adverse effects of antiretroviral therapy
    Carr, A
    Cooper, DA
    [J]. LANCET, 2000, 356 (9239) : 1423 - 1430
  • [9] Charles MA, 2002, ANN ENDOCRINOL-PARIS, V63, P154
  • [10] Cirelli Augusto, 2003, Ann Ital Med Int, V18, P238